116 related articles for article (PubMed ID: 17882940)
1. [Prevalence of neurological complications in Japanese patients with AIDS after the introduction of HAART].
Yoritaka A; Ohta K; Kishida S
Rinsho Shinkeigaku; 2007 Aug; 47(8):491-6. PubMed ID: 17882940
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
3. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
4. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
5. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
6. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
7. Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study.
Subsai K; Kanoksri S; Siwaporn C; Helen L; Kanokporn O; Wantana P
Eur J Neurol; 2006 Mar; 13(3):233-9. PubMed ID: 16618338
[TBL] [Abstract][Full Text] [Related]
8. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
Welch K; Morse A;
AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system immune reconstitution inflammatory syndrome in AIDS: experience of a Mexican neurological centre.
Guevara-Silva EA; Ramírez-Crescencio MA; Soto-Hernández JL; Cárdenas G
Clin Neurol Neurosurg; 2012 Sep; 114(7):852-61. PubMed ID: 22326129
[TBL] [Abstract][Full Text] [Related]
10. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary complications in patients with AIDS].
Oka S
Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy.
Ammassari A; Cingolani A; Pezzotti P; De Luca DA; Murri R; Giancola ML; Larocca LM; Antinori A
Neurology; 2000 Oct; 55(8):1194-200. PubMed ID: 11071499
[TBL] [Abstract][Full Text] [Related]
13. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
15. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
17. [Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].
Zhang J; Lin B; Lin L; Yang PJ; Fu JH; Li HP; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1108-11. PubMed ID: 18396667
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.
Silva MT; Araújo A
J Neurovirol; 2005; 11 Suppl 3():11-5. PubMed ID: 16540448
[TBL] [Abstract][Full Text] [Related]
19. Vacuolar myelopathy and vacuolar cerebellar leukoencephalopathy: a late complication of AIDS after highly active antiretroviral therapy-induced immune reconstitution.
Aboulafia DM; Taylor L
AIDS Patient Care STDS; 2002 Dec; 16(12):579-84. PubMed ID: 12542931
[TBL] [Abstract][Full Text] [Related]
20. Lack of change in the distribution of AIDS-defining opportunistic diseases and the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy.
Manfredi R; Calza L; Chiodo F
Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):410-3. PubMed ID: 11476442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
